Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host Diseases

by Sanfang Tu, Danli Zhong, Weixin Xie, Wenfa Huang, Yangyang Jiang, Yuhua Li
Published 2016-08-01

A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation

by Meifang Li, Jilong Yang, Lenghe Zhang, Sanfang Tu, Xuan Zhou, Ze Tan, Weijun Zhou, Yanjie He, Yuhua Li
Published 2019-05-01

Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies

by Yuru Nie, Weiqing Lu, Daiyu Chen, Huilin Tu, Zhenling Guo, Xuan Zhou, Meifang Li, Sanfang Tu, Yuhua Li
Published 2020-05-01

Design, synthesis, and biological evaluation of Bcr-Abl PROTACs to overcome T315I mutation

by Liang Jiang, Yuting Wang, Qian Li, Zhengchao Tu, Sihua Zhu, Sanfang Tu, Zhang Zhang, Ke Ding, Xiaoyun Lu
Published 2021-05-01

Consolidative Hematopoietic Stem Cell Transplantation After CD19 CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: A Systematic Review and Meta-analysis

by Xinjie Xu, Xinjie Xu, Xinjie Xu, Sifei Chen, Sifei Chen, Zijing Zhao, Zijing Zhao, Xinyi Xiao, Xinyi Xiao, Shengkang Huang, Shengkang Huang, Zhaochang Huo, Yuhua Li, Sanfang Tu
Published 2021-04-01

CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

by Sanfang Tu, Xuan Zhou, Zhenling Guo, Rui Huang, Chunyan Yue, Yanjie He, Meifang Li, Yiran Chen, YuChen Liu, Lung-ji Chang, Lung-ji Chang, Lung-ji Chang, Yuhua Li
Published 2019-12-01

Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies

by Xinjie Xu, Xinjie Xu, Qihang Sun, Qihang Sun, Xiaoqian Liang, Xiaoqian Liang, Zitong Chen, Zitong Chen, Xiaoli Zhang, Xiaoli Zhang, Xuan Zhou, Meifang Li, Huilin Tu, Huilin Tu, Yu Liu, Yu Liu, Sanfang Tu, Yuhua Li
Published 2019-11-01

Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments

by Xinjie Xu, Xinjie Xu, Xinjie Xu, Shengkang Huang, Shengkang Huang, Xinyi Xiao, Xinyi Xiao, Qihang Sun, Qihang Sun, Xiaoqian Liang, Xiaoqian Liang, Sifei Chen, Sifei Chen, Zijing Zhao, Zijing Zhao, Zhaochang Huo, Zhaochang Huo, Sanfang Tu, Yuhua Li
Published 2021-02-01

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

by Xuan Zhou, Sanfang Tu, Chunsheng Wang, Rui Huang, Lan Deng, Chaoyang Song, Chunyan Yue, Yanjie He, Jilong Yang, Zhao Liang, Anqin Wu, Meifang Li, Weijun Zhou, Jingwen Du, Zhenling Guo, Yongqian Li, Cheng Jiao, Yuchen Liu, Lung-Ji Chang, Lung-Ji Chang, Yuhua Li, Yuhua Li
Published 2020-11-01